Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-17

Clinical Trial Update: Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological Disorder

View source ↗

Summary

Clinical trial update on Fevarin® (fluvoxamine) effectiveness in treating depression in patients with a neurological disorder; study completed with posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fevarin (fluvoxamine)

Snippet

Sponsor: Abbott | Conditions: Depression | Status: COMPLETED | Results posted: 2018-12-17